...Another single stock opportunity that is worth building a bridge over; ABUS (Arbutus Biopharma) an excellent and cheap shelter for the next chapter in covid flows.
The beauty of choice! It is interesting as all covid vaccines will have to RNA IP .. this is a convincing driver.
As well as creating a shelter, use the intimately linked highs to add and build more on the position once it starts working. I am looking for an +80% move to the upside over the coming weeks.
Thanks as usual for keeping the feedback coming 👍 or 👎
Thoughts on how this performs moving forward after today's breakout? Seems as if your chart still stands true in the current scenario.
Oscarthefuzz
⋅
@MAKrisp, Just stay in, lots of news to come plus 12 week data from Hep B and Phase 2 trials kicking off, Pfizer mol% ratios issued yesterday for LNP match ABUS patent and Moderna will follow but not for a while more than likely , we will see if there's injunctive action coming or talks going on behind the scenes in early 2021. Hold firm, another 100% on the way
VooDoo7227
⋅
Update?
Oscarthefuzz
⋅
And you didn't even mention the Hep B vaccine results which are the most impressive thing...
WTFpattern
⋅
I have a chunk of my portfolio earmarked for risky high potential plays, this fits, will keep a close watch on it. Thanks for the tip.